1. Scrip
  2. >>Business

Flagship Pioneering Nurtures Unique Start-Ups Until They Can Take Wing

 
• By Sten Stovall

Flagship Pioneering founder and CEO Noubar Afeyan says "watch this space" for another new start-up financing after Evelo Biosciences' successful $50m raising.

Birds
Flagship Pioneering Says It Holds On To Startups "Until They Can Fly" • Source: Shutterstock

Life sciences investor Flagship Pioneering says the successful fund raising this month by home-grown Evelo Biosciences Inc. further validates its business model to create, nurture then launch first-in-category biotech platforms.

Evelo Biosciences raised $50m July 11 to take its monoclonal microbials into the clinic

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business

In Brief: US FDA Delay Sends Biohaven Shares Down

 
• By Andrew McConaghie

The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.

In Brief: Sanofi Commits $20bn To US R&D And Manufacturing By 2030

 
• By Sushmita Panda

Move by French major aligns with broader industry efforts to localize production amid political pressure, as Trump pushes to onshore manufacturing and hints at easing tariff threats.

Eisai Forecasts 73% Leqembi Sales Rise In FY25 As Demand Expands

 
• By Mandy Jackson

Eisai spent most of its FY24 earnings call discussing plans for growing sales of Biogen-partnered Alzheimer’s drug Leqembi from JPY44.3bn ($304.1m) to JPY76.5bn ($525.1m) in FY25.